AIFM1 Gene CMTX4 NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The AIFM1 Gene CMTX4 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying mutations in the AIFM1 (Apoptosis-Inducing Factor Mitochondria-Associated 1) gene, which is directly associated with Charcot-Marie-Tooth disease type X4 (CMTX4). This X-linked neurological disorder affects the peripheral nervous system, leading to progressive muscle weakness and sensory impairments. Our advanced next-generation sequencing technology provides unparalleled accuracy in detecting genetic variations that contribute to this complex condition.
What This Test Measures and Detects
This comprehensive genetic analysis specifically targets:
- Mutations in the AIFM1 gene located on the X chromosome
- Pathogenic variants associated with CMTX4 inheritance patterns
- Genetic markers for progressive peripheral neuropathy
- X-linked inheritance patterns affecting neurological function
- Mitochondrial apoptosis-related genetic abnormalities
Who Should Consider This Genetic Test
This test is particularly recommended for individuals experiencing:
- Progressive muscle weakness in hands and feet
- Sensory loss and numbness in extremities
- Difficulty walking or frequent tripping
- Family history of neurological disorders
- Unexplained peripheral neuropathy symptoms
- Suspected X-linked inheritance patterns
- Progressive hearing loss with neurological symptoms
Significant Benefits of Genetic Testing
Undergoing the AIFM1 Gene CMTX4 NGS Genetic DNA Test provides numerous advantages:
- Accurate diagnosis and differentiation from other neurological conditions
- Clear understanding of inheritance patterns for family planning
- Personalized treatment and management strategies
- Early intervention opportunities for affected family members
- Reduction of diagnostic uncertainty and medical costs
- Comprehensive genetic counseling based on precise results
Understanding Your Test Results
Our genetic specialists provide detailed interpretation of your results:
- Positive Result: Indicates presence of AIFM1 gene mutation, confirming CMTX4 diagnosis and enabling targeted management
- Negative Result: Suggests absence of tested AIFM1 mutations, though other genetic or non-genetic causes should be considered
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Important for family members and reproductive planning
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our comprehensive network ensures accessible genetic testing services for patients nationwide.
Take Control of Your Neurological Health
Don’t let uncertainty about neurological symptoms affect your quality of life. The AIFM1 Gene CMTX4 NGS Genetic DNA Test provides definitive answers and empowers you with knowledge about your genetic health. Our team of genetic counselors and neurological specialists are ready to support you through every step of the testing process.
Book your genetic test today by calling +1(267) 388-9828 or schedule your appointment online. Take the first step toward understanding your neurological health with confidence and clarity.
